News & Events
1 July 2026
NICE Surgical Solutions Pte Ltd (“NICE Surgical“), a clinical-stage medical device company pioneering full intracorporeal anastomosis surgical instruments has been officially granted the U.S. Patent No. 12,653,527 B2, for its purse-string stapler.
This newly granted patent covers the efficient application of a purse-string suture around the tissue adjacent to the open lumen during the colorectal surgery. The suture enables the effective closure of the colon providing a full intracorporeal anastomosis at the completion of the surgery. The award of the patent validates NICE Surgical’s use of advanced innovative medical solutions to improve surgical outcomes and the quality of life of patients.
The patented technology enables colorectal surgery to be completed minimally invasively, without an incision to the abdomen, as currently practiced. The use of NICE Surgical’s device potentially increases the efficiency in surgery and reduces surgical site infections, usually associated with surgical incisions.
NICE Surgical is a portfolio company of Trendlines Medical Singapore Pte Ltd.
This patent is a testament to the dedication and ingenuity of the research and development team at NICE Surgical. With NICE Surgical’s development progression, including human clinical studies by Q4 2026, this milestone further strengthens our validated technology.
Haim Brosh, CEO of Trendlines
Medical innovation transforms scientific discovery into better patient outcomes. I am excited that the grant of this patent acknowledges the novelty, ingenuity and potential societal value of our medical innovation.
Eric Haas, MD, Chief of Colorectal Surgery, Houston Methodist Hospital and Co-founder and Inventor of NICE Surgical
Escala Secures $4.5M in Funding to Accelerate Global Expansion of Its FDA-Approved Medical Device
Co-financing by the EIC Fund to ramp up women’s health solution to POP
Phytolon Secures Funding from Rich Products Ventures to Bring Natural Food Colors to Market